Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Chloroquine Phosphate 16.7 mg/ml Oral Suspension is a liquid formulation that provides a uniform dispersion of ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Chloroquine Phosphate 16.7 mg/ml Oral Suspension is a prescription medication that is used to treat a variety of diseases. This includes malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Chloroquine Phosphate works by killing these parasites, effectively treating and preventing malaria.
In addition to malaria, Chloroquine Phosphate 16.7 mg/ml Oral Suspension is also used to treat amebiasis, an infection caused by a parasite. This infection can lead to symptoms such as diarrhea, abdominal pain, and fever. By preventing the growth and spread of the parasite, this medication can effectively treat amebiasis.
Chloroquine Phosphate 16.7 mg/ml Oral Suspension is also used to treat rheumatoid arthritis, an autoimmune disorder that causes inflammation and pain in the joints. It works by reducing inflammation, thereby relieving the symptoms of rheumatoid arthritis.
This medication is available in a liquid dosage form, where one or more ingredients are dispersed uniformly throughout a liquid medium. This provides a homogeneous mixture for administration, ensuring that each dose contains the correct amount of medication. It is important to take this medication as directed by your healthcare provider, usually with food or milk to reduce stomach upset.
While taking Chloroquine Phosphate 16.7 mg/ml Oral Suspension, it is important to stay hydrated by drinking plenty of fluids. This can help to prevent dehydration, a potential side effect of this medication. Other common side effects include nausea, vomiting, headache, and dizziness. If you experience any of these side effects, or if they worsen, it is important to contact your healthcare provider immediately.
At Bayview Pharmacy, we are dedicated to providing our customers with the highest quality of care. If you have any questions about Chloroquine Phosphate 16.7 mg/ml Oral Suspension or any other medication, please do not hesitate to reach out to us. Our team is here to help you make informed decisions about your health.
Chloroquine Phosphate 16.7 mg/ml Oral Suspension is a compounded formulation designed for the treatment of various conditions including malaria, amebiasis, and extraintestinal amebiasis. The formulation is a liquid dosage form, where one or more ingredients are uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration.
It's important to note that Chloroquine Phosphate 16.7 mg/ml Oral Suspension may interact with other medications. These include but are not limited to antacids, cimetidine, cyclosporine, digoxin, mefloquine, quinine, and tetracyclines. Therefore, patients are advised to inform their healthcare provider of all medications they are currently taking. This includes over-the-counter medications, vitamins, and herbal supplements.
Patients should also be aware of potential side effects associated with Chloroquine Phosphate 16.7 mg/ml Oral Suspension. These may include nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, and rash. If any of these side effects are experienced, patients should immediately contact their healthcare provider.
Furthermore, it's crucial to understand that Chloroquine Phosphate 16.7 mg/ml Oral Suspension may increase the risk of developing retinopathy. Therefore, regular eye examinations are recommended while on this medication. If you have any questions or concerns about the use of Chloroquine Phosphate 16.7 mg/ml Oral Suspension, please consult with your healthcare provider.
Chloroquine Phosphate 16.7 mg/ml Oral Suspension is a liquid medication that is used to treat a variety of conditions including malaria, amebiasis, and rheumatoid arthritis. This formulation is designed to ensure that the active ingredients are uniformly dispersed throughout the liquid medium, providing a homogeneous mixture for administration.
The medication works by inhibiting the growth of parasites within the body. In the case of malaria, Chloroquine Phosphate prevents the parasites from entering the red blood cells, thereby stopping the disease from progressing. For amebiasis, the medication works by directly killing the parasites in the intestines. In the treatment of rheumatoid arthritis, Chloroquine Phosphate reduces inflammation and pain, providing relief to the patient.
Chloroquine Phosphate 16.7 mg/ml Oral Suspension is typically taken orally, once or twice daily as prescribed by a healthcare professional. It is crucial to follow the prescribed dosage and not to take more or less than recommended. To minimize potential stomach upset, it is advised to take this medication with food or milk.
It is of utmost importance to complete the entire course of the medication, even if symptoms begin to improve. Discontinuing the medication prematurely may allow the parasites to continue to grow, potentially leading to a relapse of the infection.
If you have any questions or concerns regarding Chloroquine Phosphate 16.7 mg/ml Oral Suspension, please do not hesitate to reach out. We are here to provide assistance and support throughout your treatment journey.
Chloroquine Phosphate 16.7 mg/ml Oral Suspension is a compounded formulation that has been utilized in the treatment of various conditions. This formulation has also been used in the management of discoid and systemic lupus erythematosus, which are autoimmune disorders.
Furthermore, Chloroquine Phosphate 16.7 mg/ml Oral Suspension has been used to treat polymyositis, an inflammatory disorder that affects the muscles, and sarcoidosis, an inflammatory disorder that primarily affects the lungs. It has also been beneficial in the treatment of dermatomyositis, an inflammatory disorder that affects both the skin and muscles, and Behcet's disease, an inflammatory disorder that affects the blood vessels.
Additionally, Chloroquine Phosphate 16.7 mg/ml Oral Suspension has been used in the treatment of other inflammatory and autoimmune disorders. These include Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, and Porphyria Cutanea Tarda. However, it is crucial to understand that Chloroquine Phosphate 16.7 mg/ml Oral Suspension should only be used to treat conditions for which it has been specifically prescribed by a healthcare provider.
If you have any queries regarding the use of Chloroquine Phosphate 16.7 mg/ml Oral Suspension for any other conditions, it is recommended to consult with a healthcare provider. It is essential to use this medication responsibly and under the guidance of a healthcare professional to ensure its effectiveness and safety.
Chloroquine Phosphate 16.7 mg/ml Oral Suspension is a liquid medication used to treat certain types of malaria and other diseases caused by parasites. It is a homogeneous mixture where the active ingredient, Chloroquine Phosphate, is uniformly dispersed throughout a liquid medium.
This medication should be taken orally, usually with food to prevent stomach upset, as directed by your healthcare provider. The dosage and length of treatment are based on your medical condition, weight, and response to treatment.
Side effects may include stomach cramps, nausea, vomiting, headaches, and diarrhea. If these effects persist or worsen, notify your doctor or pharmacist promptly.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Some medications may interact with Chloroquine Phosphate, affecting how it works or increasing the risk of serious side effects. Always inform your healthcare provider about all the products you use, including prescription drugs, nonprescription drugs, and herbal products, before starting treatment with this medication.
Chloroquine Phosphate should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. It is not known whether this medication passes into breast milk. Consult your healthcare provider before breastfeeding.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
Alcohol may increase the risk of certain side effects of Chloroquine Phosphate. It's generally recommended to avoid or limit the consumption of alcohol while taking this medication.
If you have an allergic reaction, such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing, seek medical attention immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
